What is Cabaletta Bio, Inc. (CABA)?
Cabaletta Bio, Inc. is a biotechnology company focused on the development of gene therapies for autoimmune diseases. The company applies its expertise in cellular immunology and gene editing to create treatments targeting disorders characterized by immune system dysfunction. Its research and development efforts involve engineering T cells to modulate immune responses. Cabaletta Bio aims to address diseases with significant unmet medical needs by advancing innovative therapeutic approaches. The company collaborates with academic institutions and industry partners to support its scientific programs. Its activities encompass preclinical research, clinical development, and regulatory engagement to bring gene therapy products to market.
Cabaletta Bio, Inc. Stock Price Today: Live Overview
The price today is shaped by current session activity in Cabaletta Bio, Inc., trading at $2.9682. The price has fluctuated between $2.9218 and $3.2218 during the day, with a daily change of 0%.
FAQ: Cabaletta Bio, Inc. (CABA)
What is the current price of CABA stock?
The current price is $2.9682.
Does CABA pay dividends?
Cabaletta Bio, Inc. does not pay dividends.
Does CABA have a formal corporate presence or regional headquarters in the UAE?
Cabaletta Bio, Inc. has no official regional office, subsidiary, or registered presence in the UAE and operates through partners or distributors only.
What is CABA best known for?
The company is most famous for developing gene therapies for autoimmune diseases.
What assets are typically shown together with CABA?
Commonly shown alongside CABA: Solid Biosciences, Valneva SE, Agenus
Latest shares articles



